A Paradox and Alan Rein: Distinguished Retrovirologist Retires from the HIV DRP

With 100 online attendees, 180 in-person participants, 15 posters, 16 technologies, and 45 speakers, the 2023 Technology Showcase offered a whirlwind look into biotechnology innovation happening at the Frederick National Laboratory for Cancer Research and National Cancer Institute.

After three years of COVID-19, science has learned much about the disease and the virus that causes it, SARS-CoV-2. But in the bigger biological and clinical picture, there are still many unanswered questions, says Ligia Pinto, Ph.D. That’s what keeps her group, the Vaccine, Immunity, and Cancer Directorate at Frederick National Laboratory, working hard to hunt down answers.

Three NCI Frederick branch chiefs have joined the ranks of three esteemed societies within the last year. While they’re grateful for the honor, they’re trying to share the limelight. The three say the elections serve to applaud their teams’ contributions, acknowledge the importance of investing in other scientists, and underscore that good science happens when many minds come together.

The National Cancer Institute and Frederick National Laboratory for Cancer Research will host the Technology Showcase on Wednesday, September 6, at the FNL’s Advanced Technology Research Facility in Frederick, Md. The seventh annual event highlights NCI and FNL inventions and capabilities available to the external healthcare and biotech communities and offers the opportunity for networking with others in the biomedical research field.

The next Biotech Connector will explore advances in protein production happening in the Frederick, Md., area with talks from three experts working in the field. It is set for 8:00 a.m. on Thursday, August 31, at the Frederick National Laboratory’s Advanced Technology Research Facility in Frederick.